Artificial Tears Market Report
Global Artificial Tears Market report is segmented By Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-Based Emulsion Tears, Polythylene Glycol Based Tears, Propylene Glycol Based Tears, Sodium Hyaluronate Based Artificial Tears), Delivery Mode (Eye Drops, Ointments), Application (Dry Eyes Treatment, Contact Lenses Moisture), and Region. This report also covers the COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Artificial Tears market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Global Artificial Tears Market report is segmented By Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-Based Emulsion Tears, Polythylene Glycol Based Tears, Propylene Glycol Based Tears, Sodium Hyaluronate Based Artificial Tears), Delivery Mode ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Artificial Tears Market is projected to grow from USD 2.6 billion in 2020 to USD 3.6 billion by 2026 at a CAGR of around 5.5% during the forecast period.
Artificial tears are eye drops used to relieve dryness and irritation of the ocular surface by lubricating them. It retains moisture on the outer surface of the eyes. Artificial tears can be categorized as cellulose-derived tears, glycerine-derived tears, oil-based emulsion tears, polyethylene glycol-based tears, propylene glycol-based tears, and sodium hyaluronate-based artificial tears.
Key players operating in the global Artificial Tears market are-
The growth of the global artificial tears market is primarily driven by an increasing number of people having eye-related health issues due to dryness and irritation. Prolonged exposure to digital displays, poor eyelids, chronic conjunctivitis, and malnutrition among others has resulted in increasing cases of dry eye syndrome (DES) is likely to propel the market growth at a significant rate during the review period. In addition to this, increasing demand for technological advancement in artificial tears is likely to create lucrative opportunities for the players operating in the global market in the coming years
By delivery mode, the artificial tears market has been bifurcated into eye drops and ointments. The eye drops segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to high preference for drops over ointments among the consumers.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period.
Covid-19 outbreak impacted the growth of the artificial tears market negatively. The spread of coronavirus led to the enforcement of lockdown to curb the spread of the virus. This led to travel restrictions and supply chain disruptions, which affected the product supply and demand.
The following is a list of the customers that the Artificial Tears market aims to convert the most:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The artificial tears market size is expected to reach USD 3.6 billion in the foreseeable future.
Johnson and Johnson Services, Inc. (The U.S), Alcon Inc. (Switzerland), OASIS Medical (The U.S), AbbVie Inc. (The U.S), Bayer AG (Germany), Prestige Consumer Healthcare Inc. (The U.S), Santen Pharmaceutical Co., Ltd. (Japan), Bausch Health Companies Inc. (Canada), Akorn Inc. (The U.S) and Aurolab (India) are among the key players in the artificial tears market.
The artificial tears market is expected to witness an impressive growth of 5.5% CAGR in the coming years.
North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR.
The eye drops segment is expected to register significant growth in the artificial tears market in the coming years.
Artificial tears distributors, Artificial tears suppliers, Artificial tears manufacturers, Logistics organizations, Government bodies are the target audience in the artificial tears market.